Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and Longevity episode artwork

EPISODE · Jun 27, 2026 · 33 MIN

Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and Longevity

from The Peptide Effect

In this episode of The Peptide Effect, we explore the emerging world of apolipoprotein-targeting peptides and how they’re reshaping the future of cardiovascular and neurological research. Learn how apolipoproteins transport cholesterol throughout the body, why HDL function may be just as important as HDL levels, and how experimental peptides such as 4F, 5A, ATI-5261, FAMP, CN-105, and D6PV are being investigated for their potential to improve cholesterol metabolism, reduce inflammation, protect the brain, and support healthy aging. We’ll also discuss reverse cholesterol transport, ApoA-I, ApoE, ApoC-II, and the role these peptides may play in the future of precision medicine. Whether you’re interested in peptide science, longevity, heart health, or cutting-edge biomedical research, this episode offers a comprehensive introduction to one of the newest frontiers in peptide therapeutics.

Episode metadata supplied by the publisher feed · Published Jun 27, 2026

Embed this episode

NOW PLAYING

Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and Longevity

0:00 33:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Peptide Effect?

This episode is 33 minutes long.

When was this The Peptide Effect episode published?

This episode was published on June 27, 2026.

Can I download this The Peptide Effect episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!